Vero-lozartan

Roman name

Vero-losartan

The composition and the form of

1 tablet contains potassium lozartana 50 mg; in a contour acheikova packing 10 pcs. , in a cardboard bundle one package.

Of drugs

Gipotenzivne. Does receptors angiotenzina II (AT_1 type), decreases round, postnagruzku reduces AD system and the pressure on a small range of diseases.

Pharmacokinetics

Well drawn. Distributed relatively evenly. Metaboliziruet education active derivative.

Indications

Arterial hypertension, heart failure.

Pregnancy and lactation

In the event of a pregnancy reception should cease immediately (can cause developmental disorders or death fruit, especially in the neonatal trimester). At the time of treatment should stop breastfeeding.

Contraindications

Hypersensitivity, the children's age, pregnancy, breast-feeding.

Side-Effects

Vertigo, gipotenzia (dozozawisimaya) giperkaliemia.

Patient interaction

Compatible with other antigipertenzivei means. While dioretikov (high doses) increases the risk of excessive hypotension in patients with dehydration.

Precautions

If any of the liver (including in history) to appoint smaller doses (significantly increases the concentration of the drug in plasma, especially in cirrhosis of the liver).

Dosing and Administration

Inside, regardless of meals (under joint reception with the other antigipertenzivei drugs). When hypertension is 50 mg once a day; If necessary, increase the dose to 100 mg. Maximum gipotenzivny effect is the 3-6 weeks after the start of the reception. For patients with heart failure initial dose is 12.5 mg once a day. Dose titrated with weekly intervals (ie, 12.5 mg / day, 25 mg / day, 50 mg / day) to support medium-dose 50 mg once a day, depending on the portable product. Patients receiving high-dose dioretikov, the initial lower dose to 25 mg once a day. If any of the liver to lower doses. Patients older, and the violation of the kidney, including patients in dialysis is not required correction initial dose.

Directory → Intermedianta → Receptor antagonists angiotenzina II (At_1-podtip) → Vero-lozartan